UNSPSC 51352417: Ethinyl estradiol/norgestrel

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS200. This VA Drug Class (HS200) classifies this compound as belonging to the group CONTRACEPTIVES, SYSTEMIC.

UNSPSC 51352417 Ethinyl estradiol/norgestrel is a Commodity code covering a specific oral contraceptive formulation that state and local governments procure through pharmacy benefit programs, cooperative purchasing agreements, and direct pharmaceutical supplier contracts. State and local health agencies and purchasing coalitions source this product alongside broader generic pharmaceutical inventories to serve employee health plans, Medicaid programs, and public health clinics. Recent solicitations show that jurisdictions are acquiring this product both as part of multi-source generic drug contracts and through emerging direct-to-manufacturer purchasing models designed to reduce intermediary costs and improve supply chain efficiency.

The code shows activity primarily among state health agencies and multistate cooperative purchasing organizations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (response due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with awards effective July 1, 2026 and mandatory distribution through three authorized wholesalers. Texas Health and Human Services Commission issued a Request for Information in April 2026 to evaluate vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling state interest in alternative contracting models that bypass traditional pharmacy benefit managers and group purchasing organizations. Geographic activity centers on Texas and Minnesota, with MMCAP's cooperative structure extending to Oregon. The code sees limited standalone solicitation activity; pharmaceutical procurement at this product level is typically embedded within broader multi-source generic drug contracts and cooperative purchasing vehicles rather than issued as discrete line-item procurements.